Becton, Dickinson and Company BDX, popularly known as BD, recently launched the new BD Intraosseous (IO) Vascular Access System. The BD IO system is likely to enable access to rapid delivery of fluids ...
FRANKLIN LAKES, N.J., Oct. 30, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched the new BD® Intraosseous Vascular Access ...
Robert D. Glatter, MD: Hi and welcome. I'm Dr Robert Glatter, medical advisor for Medscape Emergency Medicine. Joining me today to discuss the outcomes of distal femoral vs tibial vs proximal humeral ...
Potential Savings of $95 Million Annually if Only Ten Percent of Central Lines Are Replaced with IO Access Success rate of 96% in establishing vascular access on first attempt; Mean time to vascular ...
Intraosseous catheterization may be used to administer fluids or medications to small mammals, particularly when intravenous access cannot be established. This column describes the necessary equipment ...
Dublin, April 15, 2022 (GLOBE NEWSWIRE) -- The "Intraosseous Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts ...
DUBLIN, April 14, 2022 /PRNewswire/ -- The 'Intraosseous Devices market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, ...
Offering includes participation from both new and existing healthcare-dedicated investors Proceeds extend the company’s cash runway into the fourth quarter of 2025 NEW YORK, August 7, 2023 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback